Trial intelligence / Profile preview

Intranasal Cocaine and Temperature Regulation During Exercise

NCT05809453Phase 2Completed

Sponsor
UT Southwestern Medical Center
Start
Sep 2023
Primary completion
Jun 2024
Modality
Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 2 trial of cocaine, sponsored by UT Southwestern Medical Center. Started Sep 2023; status: completed.

02

Drugs

cocaine

Beyond the preview

Go deeper on NCT05809453.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05809453.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call